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Erythroid cell production results from passage through cellular hierarchies dependent on differential gene expression under the control of
transcription factors responsive to changing niches. We have constructed Genetic Regulatory Networks (GRNs) describing this process, based
predominantly on mouse data. Regulatory network motifs identified in E. coli and yeast GRNs are found in combination in these GRNs. Feed-
forward motifs with autoregulation generate forward momentum and also control its rate, which is at its lowest in hematopoietic stem cells
(HSCs). The simultaneous requirement for multiple regulators in multi-input motifs (MIMs) provides tight control over expression of target genes.
Combinations of MIMs, exemplified by the SCL/LMO2 complexes, which have variable content and binding sites, explain how individual
regulators can have different targets in HSCs and erythroid cells and possibly also how HSCs maintain stem cell functions while expressing
lineage-affiliated genes at low level, so-called multi-lineage priming. MIMs combined with cross-antagonism describe the relationship between
PU.1 and GATA-1 and between two of their target genes, Fli-1 and EKLF, with victory for GATA-1 and EKLF leading to erythroid lineage
specification. These GRNs are useful repositories for current regulatory information, are accessible in interactive form via the internet, enable the
consequences of perturbation to be predicted, and can act as seed networks to organize the rapidly accumulating microarray data.
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Over recent years, the volume of data concerning the prog-
ramming of blood lineages has expanded considerably. One way
to collate these data is to construct genetic regulatory networks
(GRNs) depicting the interactions between the individual genes.
A number of developmental processes have now been
represented as GRNs, providing insight into their underlying
molecular mechanisms (Cripps and Olson, 2002; Davidson et
al., 2002; Howard and Davidson, 2004; Loose and Patient,
2004).
A comprehensive analysis of regulatory interactions in yeast
and E. coli GRNs has resulted in the distillation of distinct
network motifs (Table 1) (Lee et al., 2002; Shen-Orr et al.,
2002). The individual network motifs can be considered as⁎ Corresponding author. Fax: +44 115 82 30313.
E-mail address: matt.loose@nottingham.ac.uk (M. Loose).
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doi:10.1016/j.ydbio.2006.02.051small networks with distinct properties, which in combination
define the genetic control of the cells' transcription programmes
(Howard and Davidson, 2004). For example, autoregulation and
multi-component loops, where transcription factors (TFs)
stimulate their own expression either directly or through an
intermediate, function to maintain gene expression programmes
(Table 1A–B). In the single-input motif (SIM), one TF activates
multiple targets (Table 1C), while multi-input motifs (MIMs)
require several TFs to activate a group of targets (Table 1D–E).
Regulatory chains, a number of TFs acting in a series, and the
more complex feed-forward loop, provide temporal control
within networks (Table 1F–G).
Here, we have constructed and analyzed GRNs underlying
the specification of the hematopoietic stem cell (HSC) and its
subsequent differentiation to the erythroid lineage, mainly
focusing on the mouse. We have analyzed the use of different
network motifs within the GRNs and relate this to the biology
of hematopoietic and erythroid development. Interactions are
Table 1
Network motifs
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experiments and cis-regulatory elements identified in promoters
and enhancers of target genes, as previously described in our
GRN for mesendoderm formation in Xenopus (Loose and
Patient, 2004). Note that only those genes and interactions
specifying the erythroid lineage via the HSC are depicted. Some
significant TFs, for example Runx1, currently play minor roles
in the GRNs, reflecting a lack of information rather than
importance (see Otto et al. (2003) for a review of Runx1). A
summary of the evidence and data for each link is available viathe accompanying website and Table S1, along with interactive
versions of these networks, which allow the upstream regulators
and downstream targets of individual TFs to be highlighted
(http://www.nottingham.ac.uk/genetics/networks/mouse and
Table S1). We acknowledge that there are many links and
genes missing from the network in its current form and that the
reliability of individual links within the network depends on the
evaluation of the source data. As a consequence, we will
continue to update the network and welcome submission of new
links via our website.
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in various cell lines and so may not fully recapitulate in vivo
regulation (the cell lines used for each interaction are
identified in Supplementary Table S1 and via our website).
However, by combining this evidence for interaction with a
knowledge of the expression profiles of the interacting
genes, the control mechanisms underlying hematopoiesis can
be predicted. In many cases, these mechanisms support
existing observations, but novel predictions that lend
themselves to subsequent experimental validation are also
generated. We use an accepted cellular hierarchy (Fig. 1) in
relation to in vitro and in vivo regulatory gene expression
patterns (Table 2) to establish the relative timings of
interactions in the network. There is agreement that the
adult hierarchy is established with the LTR-HSC, which
gives rise to the STR-HSC. The fate of the STR-HSC,
however, is in dispute: it either differentiates into a
multipotent progenitor (MPP) before differentiating into a
common myeloid progenitor (CMP) and a common lym-
phoid progenitor (CLP) (Akashi et al., 2000), or it
differentiates directly into the CMP and a lymphoid-primed
multipotent progenitor (LMPP) capable of differentiating into
either a granulocyte–macrophage progenitor (GMP) or the
CLP (Adolfsson et al., 2005; Katsura, 2002). The CMP
differentiates into either a GMP or a megakaryocyte–
erythrocyte progenitor (MEP). The final differentiation
decision involves a choice between the megakaryocyte and
erythroid lineages (Akashi et al., 2000; Koury et al., 2002).
As cells progress down the hierarchy, their lineage potential
decreases as they become more differentiated, preventing them
moving back up the hierarchy. An individual cell can be said
to have forward momentum, driving it towards a differentiated
phenotype. Consideration of the networks of TF interactions
should shed light on these aspects of hematopoietic differen-
tiation. One would also hope to glimpse mechanistic
explanations for multi-lineage priming, where lineage-specific
genes are expressed prior to lineage commitment (Hu et al.,
1997), and for how HSCs escape forward momentum and
retain pluripotency.
Results and discussion
GRNs for erythroid development
Published data have been compiled into two global erythroid
networks in different formats (Figs. 2, 3). The first global
representation of the erythroid network is the topological view
(Fig. 2) (Schlitt and Brazma, 2005). In this view, we reflect the
known connections between transcription factors identified in a
range of cell lines, ignoring the distinction between DNA
binding and non-binding TFs, and not including expression data
or timing on the network. This type of representation has been
the focus of much recent research, particularly when extracting
networks from microarray data (Han et al., 2004; Manke et al.,
2003), and can aid in identifying network motifs within a
network. The topological model allows the consideration of all
possible regulatory events that could be occurring at any giventime point in development. It is therefore essential to verify
experimentally the predictions made from a topological model.
In this respect, the network presented here can act as a seed
network for comparison with microarray data.
As experimental evidence about interactions increases, it is
possible to begin to define the logic of the network. The control
logic network (Fig. 3) represents each interaction as either
activating or repressing and describes, where known, interac-
tions between inputs on the cis-regulatory elements described
in the literature. Genes within the network are temporally
ordered from top to bottom with respect to their expression.
Thus, genes appear within the network in the approximate
sequence in which they are activated during development. If a
gene is subsequently inactivated, it is re-drawn within the
network at the appropriate time. This view therefore best
represents what is known, and what can be predicted, about
each developmental stage and allows us to consider the
underlying biological decisions being taken by the cell.
Furthermore, this view is required to understand the complexity
of the topological model, illustrating how different network
components can be used again and again at different time
points during development.
Network motifs
Within the erythroid GRN it is possible to identify auto-
regulation, multi-input and feed-forward motifs (Table 1) (Lee
et al., 2002; Shen-Orr et al., 2002; Yu et al., 2003). These
network motifs are combined and inter-linked, consistent with
the view that GRNs are built from simple recurrent patterns of
interactions (Babu et al., 2004). We consider the occurrence of
these network motifs within the GRN and relate their use to the
biology of erythroid development.
The multi-input motif (MIM)—co-ordinating gene expression
The MIM defines the regulation of a group of target genes
by the same set of TFs. This mechanism results in a highly
controlled gene expression programme, whereby full activa-
tion of targets only occurs when all the regulators are present.
An example is the regulation of SCL and Hex (PRH), by Fli-1,
Elf-1 (both Ets TFs) and GATA-2 (Fig. 4A). In the multi-
potential 416B cell line, GATA-2, Fli-1, and Elf-1 together
direct SCL expression via a 3′ enhancer (Gottgens et al.,
2002). All three binding sites are required for enhancer
activity. Elf-1 expression has not yet been detected in blood
precursors in mouse, Xenopus, or zebrafish embryos so, since
Fli-1 can compensate for Elf-1 at these Ets sites, it is possible
the MIM may only involve Fli-1 and GATA-2 or that another
Ets factor is involved. Similarly, the SCL null phenotype is not
recapitulated in the Fli-1, Elf-1, or GATA-2 knockouts,
suggesting that other Ets and GATA TFs may be able to
compensate for the loss of individual regulators (Gottgens et
al., 2002, 2004; Ohneda and Yamamoto, 2002). Recent
evidence shows that Hex is regulated via an intronic enhancer
region containing Ets-Ets-GATA sites bound by Elf-1, GATA-
2, and Fli-1 in 416B cells (Donaldson et al., 2005). Hex and
SCL are thought to play important roles in early hematopoietic
Fig. 1. A hierarchy of cellular differentiation depicting the emergence of the erythroid lineage from mesoderm. The hematopoietic hierarchy is based on in vitro and
in vivo (where available) gene expression. The GRNs described are based on this depiction of cellular relationships. The earliest precursors of both primitive and
definitive hematopoietic cells and endothelial cells are poorly defined and hence the data used is based on in vitro evidence. It is unknown if the definitive HSC
develops from a hemangioblast population or from an endothelial population known as hemogenic endothelium. These two populations themselves can be difficult
to distinguish between, with markers for both endothelial and hematopoietic cells identified in cell populations (Lacaud et al., 2002; North et al., 2002). Two
alternative schemes are current (i and ii) describing the transition from the short-term repopulating stem cell (STR-HSC) to the MEP. In the first scheme (i), the
STR-HSC gives rise to a multi-potent progenitor (MPP) capable of differentiating into the CMP or CLP. However, evidence for a lymphoid primed multipotent
progenitor (LMPP) capable of differentiating into either GMP or CLP has also been proposed, giving rise to the second scheme (ii) (Adolfsson et al., 2005;
Katsura, 2002). Arrows indicate the general progression of differentiation; dashed lines represent cell types not shown. E—embryonic day, EC—endothelial cell,
LTR—long-term repopulating, HSC—hematopoietic stem cell, STR—short-term repopulating, MPP—multi-potent progenitor, CMP—common myeloid
progenitor, CLP—common lymphoid progenitor, MEP—megakaryocyte erythroid progenitor, GMP—granulocyte-macrophage progenitor, BFU-E (meg)—burst
forming unit erythroid (megakaryocyte), CFU-E (GM)—colony-forming unit erythroid (granulocyte/macrophage), Pro-eryb—pro-erythroblast, Baso-eryb—
basophilic erythroblast, Ery—erythrocyte, EryP-CFC—primitive erythroid precursors.
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Table 2
Expression patterns of key genes in the hierarchy
Note. * = In vitro evidence, + = gene known to be expressed.
− = Gene known not to be expressed.
± = Gene expressed at low level + (−) = gene expressed, but declining beyond this stage.
? = Not shown to be expressed but presumed because cells above and below in hierarchy show expression.
References: Akashi et al., 2000; Anguita et al., 2004; Chung et al., 2002; Emambokus et al., 2003; Endoh et al., 2002; Fehling et al., 2003; Fujimoto et al., 2001; Hirai et al., 2003; Lacaud et al., 2002; Lecuyer et al., 2002;
Minegeshi et al., 1999; North et al., 2004; Orkin, 1995; Shivdasani, 2001; Spyropoulos et al., 2000; Suzuki et al., 2003; Ziegler et al., 1999.
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Fig. 2. Topological GRN. A topological representation of the network; all possible interactions are shown. There is no discrimination between direct and indirect
targets or protein–DNA and protein–protein interactions. When viewed with YED (available via our website http://www.nottingham.ac.uk/genetics/networks/mouse)
this view allows easier identification of network motifs because the logic surrounding the interactions is not represented.
530 G. Swiers et al. / Developmental Biology 294 (2006) 525–540development (Guo et al., 2003; Lecuyer and Hoang, 2004).
Their regulation by a MIM suggests that the co-ordinated
activation of targets will occur only when all the regulators
(GATA-2, Fli-1, and possibly Elf-1) are present. Given that
these regulators are themselves regulated by signals (BMP and
Notch, Fig. 3), the MIM provides temporal and spatial control
via these signals over the expression of hematopoietic genes.
However, the observed redundancy in this system, demon-
strated by the ability to utilize alternative GATA/Ets factors,
together with the knowledge that SCL is essential for
hematopoiesis and embryo survival (Lecuyer and Hoang,
2004), raises the possibility that back up circuitry has evolved
(Kafri et al., 2005).
More commonly seen is the regulation of a set of target genes
by a group of TFs such that different TF combinations regulate
different target genes (sometimes referred to as a Dense
Overlapping Region or DOR) (Shen-Orr et al., 2002). Thus,
different groups of target genes are expressed depending on the
particular subset of regulatory TFs present in the cell. Examples
include the SCL complexes (Fig. 4B) (Wadman et al., 1997).
Within the hematopoietic hierarchy, SCL complexes are
implicated in the regulation of GATA-1, c-kit, α-globin, P4.2,
and GPA among many other potential targets, but each of theseig. 3. Control Logic GRN. A control logic model of erythroid development describing known interactions important in the development of the erythroid lineage. The
enes have been positioned in the network so that genes expressed at early developmental stages are positioned towards the top of the figure and vice versa based on
able 2 and Fig. 1. The colored panels behind the network reveal the approximate position in the hierarchy (Fig. 1) that the genes are first expressed (note that genes
ay continue to be expressed into other lineages). Genes repeated in the network in different positions highlight the different behavior important at different stages.t -
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r -
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F
g
T
mts is regulated by a different SCL complex. SCL, E2A, Ldb1,
and LMO2 are common to all known SCL complexes, with a
GATA factor required for all the above targets except for the
repression of c-kit (Vitelli et al., 2000). This core complex of 5
factors can be seen to regulate GATA-1 expression (Patterson et
al., 2005; Vyas et al., 1999) and P4.2 (Xu et al., 2003). The
disparity between the expression times of these two genes may
be explained by the preference for a particular GATA factor,
GATA-2 for GATA-1 regulation and GATA-1 for P4.2
regulation, or by the requirement for other factors for activation
or to alter the chromatin state. Other TFs, such as NFE2 or Sp1,
are present in the complex for some target genes and are often
required for maximal activation of individual targets (Anguita
et al., 2004). In MEL cells, GATA-1 or SCL/E2A alone
weakly activate P4.2, and this activation is greatly enhanced
when LMO2 is present in the complex and maximally
activated when all factors and Ldb1 are present (Xu et al.,
2003). In contrast, SCL, E2A, GATA-2, LMO2, Ldb1, and
Sp-1 are all required for c-kit activation, with GATA-1 able to
minimally compensate for the loss of GATA-2 in this complex
(Lecuyer et al., 2002). Not only are these complexes all
different in terms of makeup, each also binds to the regulatory
elements in different ways, for example, via GATA-1 (Anguita
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Fig. 4. The multi-input motif. (A)Hex and SCL are regulated by Fli-1, Elf-1 and GATA-2 via Ets-Ets-GATA sites that function with AND logic. Fli-1 may substitute for
Elf-1 in vivo, see text for more details. The OR logic under SCL shows that this SCL 3′ enhancer may be redundant. Fli-1 is both a regulator (along with Elf-1 and
GATA-2) and a target of the MIM, and it is possible that other Ets and GATA factors regulate these binding sites. This leads to the observation that this MIM also
contains feed-forward network motifs, such as where GATA-2 acts to regulate Fli-1 and SCL/Hex or Elf-1 regulates Fli-1 and SCL/Hex. (B) A topological network
depicting a dense overlapping region (DOR) in the erythroid network based on the SCL complex. Some of the regulators are common to all target genes and have MIM
properties (SCL, E2A, LMO2, Ldb1). GATA-1 and GATA-2 participate in regulating a subset of the target genes whereas others (e.g., NF-E2) only regulate certain
targets. C-kit is both activated (left side) and repressed (right side) with Sp1 and a GATA factor involved in activation and Rb involved in repression. The precise logic
regulating the targets varies and is dependent on individual target genes. Greyed out genes represent genes that are off, genes in color are on.
532 G. Swiers et al. / Developmental Biology 294 (2006) 525–540et al., 2004) or Sp-1 (Lecuyer et al., 2002) or the SCL/E2A
proteins (Vitelli et al., 2000). This suggests that SCL
complexes can recognize a variety of different binding sites.
This variety in complex components and DNA binding
mechanisms is likely to contribute to the differences in
expression timing of SCL targets, with some targets expressed
in the HSC and others expressed solely within the erythroid
lineage.
These DORs (Table 1E; Fig. 4B) could therefore maintain
expression of a core gene subset while allowing switching
between alternative sets of lineage-affiliated targets, thus
providing a potential mechanistic explanation for multi-lineage
priming (Hu et al., 1997). The low level of expression of
lineage-affiliated targets in multi-potential stem/progenitor cells
would then reflect the absence of a full complement of complex
components for their promoters/enhancers. As the number of
components increases during differentiation, the available gene
expression profiles would be reduced until only one develop-
mental pathway is selected.Feed-forward motifs—temporal control of gene expression
Feed-forward motifs occur when one transcription factor
regulates an intermediate, with either or both required for
regulation of a third target gene (Table 1G; Fig. 5A) (Lee et
al., 2002). Feed-forward motifs can be characterized with
respect to the underlying Boolean logic, AND or OR. In
AND feed-forward loops, the target gene can only be
activated in response to persistent expression of both
upstream genes, resulting in a delay in activation of the
target gene. OR feed-forward loops protect the target from
transient inactivation of either of the input signals and
maintain target gene expression (Ma et al., 2004; Mangan et
al., 2003). We have identified a large number of feed-
forward motifs within the GRN of both AND and OR logic
(Table 3).
As an example, β-globin is regulated by two interlinked
feed-forward motifs, involving GATA-1 with either EKLF or
FOG-1 (Fig. 5B). GATA-1 activates FOG-1 which is
absolutely required for GATA-1 mediated regulation of β-
Fig. 5. Feed-Forward Motifs. (A) The basic feed-forward loop whereby the target, gene C, is regulated directly by the regulator, gene A, and indirectly via an
intermediate, gene B, providing forward momentum to the GRN. Genes A, B, and C are positioned with respect to the onset of their expression.(B) β-globin is
regulated by two feed-forward loops with GATA-1 as the regulator in both cases and EKLF and FOG-1 as the intermediates. Neither feed-forward loop can recapitulate
normal β-globin expression alone, suggesting that the two loops are inter-related. GATA-1 activates FOG-1, functioning with AND logic to bind and regulate β-globin
via GATA binding sites. GATA-1 also activates expression of EKLF. Both EKLF and GATA-1 (in association with FOG-1) can bind to and regulate the β-globin LCR.
(C)GATA-2 and c-myb are the targets of a negative feed-forward loop with GATA-1 as the regulator and FOG-1 as the intermediate. Both of the feed-forward loops are
AND logic. The diamond on c-myb is to show that the presence of FOG-1 switches from GATA-1 activation to GATA-1/FOG-1 repression.
Table 3
Feed-forward loops within the network
Upstream Intermediate Target Logic
GATA-1 EKLF β-globin And Fig. 5B
GATA-1 Fog-1 β-globin And Fig. 5B
GATA-2 Fli-1 SCL And Fig. 4A
GATA-2 Fli-1 Hex And Fig. 4A
Elf-1 Fli-1 SCL Or Fig. 4A
Elf-1 Fli-1 Hex Or Fig. 4A
GATA-2 SCL c-myb And Fig. 2
GATA-1 FOG-1 GATA-2 And Fig. 5C
GATA-1 FOG-1 c-myb And Fig. 5C
BMP-4 GATA-1 EKLF Or Fig. 2
GATA-1 FOG-1 α-globin And Fig. 2
GATA-2 SCL GATA-1 Unknown Fig. 2
GATA-1 P45-NFE2 α-globin And Fig. 2
GATA-1 P45-NFE2 β-globin And Fig. 2
SCL GATA-1 P4.2 Or Fig. 2
SCL GATA-1 GPA Or Fig. 2
SCL GATA-1 α-globin And Fig. 2
SCL GATA-1 c-myb Unknown Fig. 2
GATA-1 FOG-1 GPA Or Fig. 2
533G. Swiers et al. / Developmental Biology 294 (2006) 525–540globin at GATA binding sites (Letting et al., 2004; Welch et
al., 2004). The physical interaction between FOG-1 and
GATA-1 provides a mechanism for the AND logic observed
at this site and may help prevent premature activation of β-
globin. The second feed-forward loop regulating β-globin
involves EKLF and GATA-1 (Fig. 5B) (Asano and Stama-
toyannopoulos, 1998; Donze et al., 1995; Letting et al., 2003,
2004). These two loops are inter-dependent as a GATA-1
mutant, unable to bind FOG-1, results in β-globin expression
levels equivalent to those seen in a GATA-1 null cell line
(Coghill et al., 2001; Letting et al., 2004; Weiss et al., 1997).
β-globin is also expressed at weak levels in EKLF null cells
(Coghill et al., 2001; Weiss et al., 1997), further supporting
the idea that these two feed-forward loops are inter-
dependent. The residual weak expression of β-globin may
be a consequence of TFs able to compensate for GATA-1 and
EKLF (GATA-2 levels are upregulated in GATA-1 null cells,
for example) (Coghill et al., 2001; Weiss et al., 1997). The
dependence of these two AND feed-forward motifs on
expression of intermediates predicts a delay in the activation
of the target following GATA-1 expression (Mangan et al.,
2003).
The SCL 3′ enhancer and the intronic enhancer in Hex
are also involved in a feed-forward motif, further supporting
the observation that expression of these two genes is initiated
in a similar fashion (Fig. 4A) (Donaldson et al., 2005; Guo
et al., 2003; Lecuyer and Hoang, 2004). GATA-2 and Fli-1
both activate SCL and Hex, with GATA-2 also able to
activate Fli-1. Elf-1, another Ets factor, is also involved in
these activations, although the precise nature of its role in
activating the hematopoietic programme during development
is not clear. Again, we see two inter-related feed-forward
loops functioning on one promoter/enhancer. The two feed-
forward loops may be linked by AND logic at the 3′
enhancer in SCL requiring Fli-1 or Elf-1 and GATA-2 to be
present. However, the SCL 3′ enhancer is not necessary for
the activation of SCL (Gottgens et al., 2004). Fli-1 and Elf-1also participate in SCL regulation via a 5′ enhancer, with Fli-
1 and Elf-1 interacting with AND logic involving five
individual Ets sites (Fig. 4A) (Gottgens et al., 2004). Thus,
SCL is controlled by two interlinked, feed-forward loops, one
of which may be active at both the 3′ and 5′ enhancers. Hex
may also be regulated by both feed-forward loops, though
only at one intronic enhancer region. Again, the AND logic
in the feed-forward loops ensures that SCL and Hex are only
expressed when all the regulators are present at sufficient
levels.
Cross-antagonistic switches—lineage choice
Differentiation of the HSC to the erythroid lineage results
from specific decisions taken at multiple stages, each involving
a switch with a choice between different developmental
534 G. Swiers et al. / Developmental Biology 294 (2006) 525–540pathways (Akashi et al., 2000; Cantor and Orkin, 2001). Such
decisions are a feature of multi-cellular organisms, and
therefore, it is not surprising that a version of the multi-input
motif not previously emphasized in E. coli and yeast has been
proposed as one of the key mechanisms involved. However,
such competition does occur in these organisms and in these
cases evidence suggests that cross-antagonism between com-
peting programmes reinforces mutual exclusivity between
programmes (Resendis-Antonio et al., 2005; Singh et al.,
2005). In an example of integrating data from many different
cell lines, the mutually antagonistic relationship between PU.1
and GATA-1 is predicted to be important in determining the
outcome of the differentiation decision from the STR-HSC via
the CMP into the GMP or MEP (Fig. 6A) (Rekhtman et al.,
2003). Sufficient levels of PU.1 will drive development
towards the GMP lineage (Fig. 6B). PU.1 binds to GATA-1
and prevents GATA-1 binding target promoters in K562 cells
(Zhang et al., 2000), and in MEL cells, PU.1 and Rb bind to
GATA-1 and prevent GATA-1 mediated regulation of its
targets (Rekhtman et al., 2003). GATA-1 can also bind PU.1
(in K562 cells) and either block its DNA-binding ability, or
block association with the co-activator, c-jun, ensuring that
PU.1 can no longer regulate its target genes thus predicted to
drive differentiation towards the MEP (Fig. 6C) (Nerlov et al.,
2000; Zhang et al., 1999). A similar cross-antagonistic switch,
involving Fli-1 and EKLF (Fig. 6D) can be observed in MEL
cells which could provide the mechanism for the decision
made when the MEP differentiates into the megakaryocyte
lineage with Fli-1 antagonizing EKLF (Fig. 6E), or into the
erythroid lineage with EKLF antagonizing Fli-1 (Fig. 6F)
(Starck et al., 2003). This network motif, the cross-
antagonistic switch, is the same as a simple MIM, although
the two upstream genes have opposing effects on the other's
targets (Fig. 6G) (Kluger et al., 2004).
These two switches appear to be linked as Fli-1 and EKLF
are themselves targets of PU.1 and GATA-1, respectively,
allowing a model of lineage choice to be built (Fig. 6H,
predicted interactions are marked with an asterisk) (Crossley
et al., 1994; Starck et al., 1999). Thus, the relative levels and
activities of PU.1 and GATA-1 would appear to be the crucial
determinants of the ultimate cell fates. Both require SCL for
their expression; however, Notch signaling positively reg-
ulates PU.1 expression (Schroeder et al., 2003) and is
assumed to indirectly negatively regulate GATA-1 activityFig. 6. Antagonistic switches-lineage decisions. The decisions involved in generati
Cross-antagonism plays an important role in fine-tuning differentiation decisions; the
have been demonstrated on artificial promoter constructs, we identify target genes ra
manner as the artificial promoter construct. (A) The lineage determining interactions t
the MEP (C). (B) PU.1 mediated antagonism of GATA-1 results in repression of the er
(C) GATA-1 mediated antagonism of PU.1 results in differentiation directed towards
important in determining the erythroid and megakaryocyte lineages is dependent on
towards the megakaryocyte lineage while repressing the erythroid lineage. (F) E
megakaryocyte lineage via Fli-1 antagonism. (H) The antagonistic switch is the unde
target while negatively regulating the target of a second TF and vice versa. A represen
is shown in (H). Although the binding sites are functional on the target genes shown
formally demonstrated on these particular promoters. These predicted interactions ar
patterns of the genes shown (Table 2).(Fig. 3) (Ishiko et al., 2005). Thus, Notch may be one of the
extrinsic cues determining lineage decision. How other
hematopoietic cytokines link into this circuitry is still being
worked out.
Autoregulation and repressive feed-forward loops—forward
momentum
Autoregulation and repressive feed-forward motifs, other-
wise known as positive and negative feedback respectively,
drive differentiation forwards by stabilizing expression of
differentiation regulators and by restricting expression of
genes important for proliferation, for example.
Autoregulation. Autoregulation occurs frequently within the
erythroid GRN with GATA-1, GATA-2, Fli-1, PU.1, and c-myb
autoregulating (Fig. 3), helping to maintain gene expression
programmes (Bolouri and Davidson, 2002). Once a TF has
established autoregulation, it becomes independent of up-
stream regulators (Howard and Davidson, 2004). As an
example, the Notch signaling pathway initiates GATA-2
expression in the definitive lineage at E9.5 and E10.5 (Fig.
3) (Robert-Moreno et al., 2005). As GATA-2 can autoregulate,
it is not dependent on maintenance of Notch signaling for the
maintenance of its expression. In a similar fashion, BMP
initiates Fli-1 expression in Xenopus laevis (Walmsley et al.,
2002) and Fli-1, with GATA-2 and Elf-1, subsequently
autoregulates to maintain its own expression. Since initiation
of SCL and Hex requires expression of both GATA-2 and an
ets factor, potentially Fli-1, it is indirectly dependent on
signaling by BMP and Notch. However, the fact that GATA-2
and Fli-1 are able to autoregulate may continue to contribute to
the maintenance of SCL and Hex expression after BMP and
Notch signaling ceases.
Repressive feed-forward loops. So far, we have considered
feed-forward loops that activate a target that has not
previously been expressed (Fig. 5A). Feed-forward loops can
also affect genes that have previously been activated,
sometimes acting to inactivate these targets. These network
motifs are acting as feedback mechanisms, inactivating genes
that are expressed during earlier stages of hematopoietic
differentiation.
Two such feed-forward motifs can be identified involving the
regulation of GATA-2 and c-myb, both of which are negativelyng the definitive erythroid lineage over myeloid and megakaryocytic lineages.
winning TF is identified in panels B,C, E, and F. Note that as these interactions
ther than specific targets. Evidence shows that α-globin is controlled in the same
hought to occur in the CMP resulting in differentiation into either the GMP (B) or
ythroid lineage and directed differentiation into the myeloid lineage via the GMP.
the megakaryocyte-erythroid lineage via the MEP. (D) The switch thought to be
EKLF and Fli-1 cross-antagonism. (E) Fli-1 expression directs differentiation
KLF expression directs fate down the erythroid lineage while repressing the
rlying mechanism for the switches in panels A–F. One TF positively regulates a
tation of the interactions important in developing the definitive erythroid lineage
, the antagonistic interactions of GATA-1, PU.1, Fli-1 and EKLF have not been
e marked with an asterisk. This network is supported by the known expression
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536 G. Swiers et al. / Developmental Biology 294 (2006) 525–540regulated by GATA-1 and Fog-1 (Fig. 5C) (Martowicz et al.,
2005; Pal et al., 2004). The absolute requirement for FOG-1
in repression of GATA-2 results in a delay of GATA-2
repression with respect to the onset of GATA-1 expression.
c-myb repression byGATA-1 and FOG-1 appears to be similar to
the regulation of GATA-2 although GATA-1 alone is able to
activate the c-myb promoter, with repression only observed
when FOG-1 is present (Bartunek et al., 2003). As aFig. 7. Forward Momentum and the Ratchet. The progression of gene expression w
network to (B) GATA-1 mediated control. (A) Autoregulation is important in maintain
point, GATA-1 and FOG-1 have not been activated. (B) GATA-1, possibly switched
expression, subsequently activating FOG-1. FOG-1 and GATA-1 then function to swi
1, but at the c-myb locus causes GATA-1 to become repressive as opposed to inductiv
unknown. (C) The switch mechanism in panels A and B is represented as found in the
switch off (Fig. 3). The block to GATA-1 activity by Notch and downstream Hes-1 act
the niche.consequence, c-myb expression would be expected to initially
increase in response to GATA-1 expression, but prolonged
GATA-1 expression, inducing FOG-1, will lead to inactivation
of c-myb. Negative feed-forward loops are important in driving
development forward, sometimes releasing the dependence of a
regulatory factor from its initiating regulation, or as here,
inactivating a previous stage of gene expression (Howard and
Davidson, 2004).ithin the definitive erythroid lineage from (A) GATA-2 mediated control of the
ing the stem cell state, with bothGATA-2 and c-myb seen to autoregulate. At this
on by GATA-2 (and the SCL complex), begins to autoregulate and maintains its
tch offGATA-2 and c-myb. FOG-1 mediates the repression of GATA-2 by GATA-
e. The precise mechanism with which FOG-1 and GATA-1 work at these loci is
main network, with genes illustrated as they switch on and then redrawn as they
ivity is illustrated, suggesting a model by which the stem cell may be held back in
537G. Swiers et al. / Developmental Biology 294 (2006) 525–540c-myb, c-myc and GATA-2 are important in the HSC and
progenitor cells, and are all switched off around the pro-
erythroblast stage of erythroid development (Emambokus et
al., 2003; Rylski et al., 2003; Sandberg et al., 2005; Tsai and
Orkin, 1997). Whereas repression of GATA-2 and c-myb
involve GATA-1 and FOG-1 (Bartunek et al., 2003;
Martowicz et al., 2005; Pal et al., 2004), whether c-myc
repression by GATA-1 also involves FOG-1 is unknown
(Rylski et al., 2003). Overall, it appears that a critical switch
during erythropoiesis is from GATA-2 mediated control of the
network to GATA-1 control, and the mechanism that underlies
this switch involves negative feed-forward loops (Figs. 5C and
7A, B). The transition appears to be gradual because BFU-Es
express GATA-1 weakly, but CFU-Es express much higher
levels (Suzuki et al., 2003).
The negative feed-forward motifs that underlie this switch
provide temporal control, delaying the repression of GATA-2
and c-myb with respect to GATA-1 expression through the
requirement for FOG-1. Autoregulation (specifically GATA-1
and GATA-2) within the feed-forward loop maintains direc-
tionality by fixing individual decisions within the network.
However, with the network demonstrating forward momentum
driving towards differentiation, how do stem cells resist? Hes1,
induced in response to Notch signaling in K562 cell lines, can
inhibit the development of the megakaryocyte and erythroid
lineages by preventing the association of GATA-1 with its co-
activator p300 (Ishiko et al., 2005). One might predict a
mechanism that could delay the GATA-2/GATA-1 switch if
Hes1 can block GATA-1 mediated repression of GATA-2 (Fig.
7C), although this has not been shown experimentally. Hes1 has
been shown to prevent differentiation in HSCs in vitro, adding
further support to a role in maintaining the undifferentiated
state, and presumably GATA-2 mediated control, of the network
(Kunisato et al., 2003). We suggest that while Hes1 is
preventing GATA-1 mediated activation of its target genes,
expression of GATA-1 continues in response to GATA-2 and the
SCL complex. This would allow GATA-1 protein levels to
accumulate and hence take part in cross-antagonistic, lineage
determining interactions for example with PU.1, while ensuring
that GATA-1 targets are only weakly expressed. If delta/jagged
expression is restricted to the stem cell niche, then departure
from the niche could be enough to trigger differentiation. This
hypothesis requires experimental validation but represents one
possible mechanism by which stem cells are maintained. This
model also provides further mechanistic insight into multi-
lineage priming.
Concluding remarks
Analysis of hematopoietic GRNs has revealed network
motifs that control specific features in the development of the
erythroid lineage. Feed-forward loops precisely control the
temporal expression of TFs throughout the hierarchy. Lineage
switches so far identified are antagonistic multi-input motifs,
representing differentiation decisions, which are aided by the use
of autoregulation, releasing them from upstream regulation. As
is increasingly being observed for GRNs in other systems, feed-forward loops are more commonly observed in switches
controlled within one lineage of cells, whereas antagonistic
multi-input motifs feature in decisions between different
programmes or lineages (Resendis-Antonio et al., 2005; Singh
et al., 2005).
Growth factors and cytokines are obviously essential to
the regulation of hematopoiesis in vivo, but the identifica-
tion of their specific TF targets is poorly understood.
Regulation of receptor expression may help to determine
which pathways are active in different cell types. Expression
of the c-kit receptor in stem cells but not in differentiating
erythroid cells allows them to respond to signaling by SCF
(Cairns et al., 2003). Notch1 is important in maintaining
GATA-2 expression (Kumano et al., 2001), and both Notch1
and Wnt signaling are thought to be important in controlling
HSC self-renewal and differentiation (Duncan et al., 2005).
We have suggested one mechanism by which Notch
signaling could prevent the GRN from moving forward;
however, a closer examination of the micro-environment in
which the stem cells reside will further define the signals
important in maintaining the stem cell state (Durand and
Dzierzak, 2005). Clearly, signaling molecules driving
differentiation may act to select specific outcomes from
underlying stochastic fluctuations of gene expression. A
more complete knowledge of the network interactions in
stem and progenitor cells will facilitate a better understand-
ing of such fluctuations.
The bias in network motif representation in these GRNs may
be at least partly a consequence of a bias in the information
available and may become less apparent as more data are
included. However, this bias also suggests that, as predicted for
mammalian systems, there is a non-random use of different
network motifs (Kluger et al., 2004). Longer regulatory chains
may occur within lineages once they have been specified, an
aspect not fully explored in our network. Combinatorial
network motifs, where feed-forward loops, multi-component
loops and autoregulation all function together can provide
complex regulation of hematopoiesis and are frequently seen in
the network. However, the dynamics of the combined network
motifs are not easily extrapolated from the individual network
motifs that comprise them. We have not identified any network
motifs that occur alone within the network, and all are part of
larger networks acting on each promoter/enhancer. Predictions
of network behavior based on simple network motifs must
always include a consideration of the biological context in
which the network motif is functioning. As we expand our
understanding of the control logic of individual promoters/
enhancers, and of the expression patterns and activities of the
regulators, predictions will become easier.
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